A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Clinical trial NCT03626688 · COMPLETED

Trial details

NCT number: NCT03626688
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

PAH Pulmonary Hypertension Pulmonary Arterial Hypertension Hypertension Connective Tissue Diseases Familial Primary Pulmonary Hypertension Vascular Diseases Cardiovascular Diseases Hypertension, Pulmonary Lung Diseases Respiratory Tract Disease

Start date: 2019-01-24
Primary completion: 2025-12-31
Enrollment: 687

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.